Variation in Body Composition on the Fate of Older Subjects During SSR Hospitalization

NCT ID: NCT04464278

Last Updated: 2020-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-31

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to correlate weight variation as well as body composition with mortality and unscheduled readmission of geriatric population

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Weight loss in obese adults confers health benefits, while weight loss in the elderly is associated with an increased risk of mortality.

There are a large number of studies associating weight loss and mortality but the relationships between changes in body composition (ratio between fat mass and lean mass) and mortality are often contradictory and poorly understood in elderly subject. The aim at this study is to request at this question.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Weight Changes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case group: weight loss ≥ 5%

No interventions assigned to this group

Control group: weight loss ≤ 5%

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient ≥70 years old
* Hospitalized in SSR for less than 7 days
* No patient opposition

Exclusion Criteria

* patient with a pacemaker
* lake of nutritional assessment on admission
* lake of assessment of autonomy at admission
* Patient under guardianship or curatorship
* Patient participating in another clinical research
* Patient for whom a short stay (\<21 days) is planned in SSR
Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

INSERM UMR S 1136

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christine FORASASSI, MD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christine FORASASSI, MD

Role: CONTACT

01 40 19 34 14

Christian AUSSEL, MD

Role: CONTACT

01 40 19 34 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IDRCB 2019-A03287-50

Identifier Type: OTHER

Identifier Source: secondary_id

APHP200265

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PREPA PREvention of Loss of Autonomy
NCT03667664 ACTIVE_NOT_RECRUITING NA